Disclosures for "Association of Structural Imaging of Hippocampal and Regional Brain Volumes with Retinal Optical Coherence Tomography Imaging in the Aging-MCI-AD Continuum: An ONDRI Study"
-
Mr. Banihashemi has nothing to disclose.
-
The institution of Dr. Swartz has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Swartz has received research support from Ontario Brain Institute.
-
Dr. Kertes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novelty Nobility. Dr. Kertes has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apellis. The institution of Dr. Kertes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kertes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Kertes has received research support from RegenxBio. The institution of Dr. Kertes has received research support from Roche. The institution of Dr. Kertes has received research support from Novartis. The institution of Dr. Kertes has received research support from Ora Gene. Dr. Kertes has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory board with Novartis. Dr. Kertes has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory board with Bayer. Dr. Kertes has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory board with Roche . Dr. Kertes has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory board with Apellis. Dr. Kertes has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Boehringer Ingelheim. Dr. Kertes has received personal compensation in the range of $500-$4,999 for serving as a Advisory board with Biogen. Dr. Kertes has received personal compensation in the range of $500-$4,999 for serving as a Advisory board with Viatris.
-
Dr. Hatch has nothing to disclose.
-
The institution of Prof. Hudson has received research support from Canada Foundation for Innovation and Ontario Research Fund. The institution of Prof. Hudson has received research support from Optina Diagnostics Inc. Prof. Hudson has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Goubran has nothing to disclose.
-
Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Limited . Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Black has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Black has received research support from Hoffmann-La Roche. The institution of Dr. Black has received research support from Biogen. The institution of Dr. Black has received research support from GE Healthcare. The institution of Dr. Black has received research support from Eli Lilly. The institution of Dr. Black has received research support from Genentech. The institution of Dr. Black has received research support from NovoNordisk. The institution of Dr. Black has received research support from UCB Biopharma. The institution of Dr. Black has received research support from Alkahest Inc. The institution of Dr. Black has received research support from University of Southern California - AHEAD 3-45 Study.